Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Клиническая эффективность обезболивания импульсной радиочастотной аблации нервных корешков у больных с метастатическим поражением позвоночника
Кузнецов С.Ф., Бабкин Н.С., Валиев А.К., Кабардаев Р.М., Борзов К.А. Клиническая эффективность обезболивания импульсной радиочастотной аблации нервных корешков у больных с метастатическим поражением позвоночника. Современная Онкология. 2024;26(4):495–503. DOI: 10.26442/18151434.2024.4.203008
© ООО «КОНСИЛИУМ МЕДИКУМ», 2024 г.
© ООО «КОНСИЛИУМ МЕДИКУМ», 2024 г.
________________________________________________
Kuznetsov SF, Babkin NS, Valiev AK, Kabardaev RM, Borzov KA. Pain relief clinical efficacy using pulsed radiofrequency ablation of nerve roots in patients with spine metastatic lesions. A prospective study. Journal of Modern Oncology. 2024;26(4):495–503. DOI: 10.26442/18151434.2024.4.203008
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Цель. Оценить анальгетическую эффективность и безопасность метода импульсной радиочастотной аблации (ИРЧА) нервных корешков спинного мозга, ее влияние на общесоматический и функциональный статус пациента и количество используемых анальгетиков у больных с метастатическим поражением позвоночника.
Материалы и методы. В работе проводился анализ данных 230 пациентов с болевым синдромом, связанным с метастатическим поражением позвоночника, участники распределены на две группы. В 1-ю группу включены 156 пациентов, которым проведена ИРЧА нервных корешков в целях облегчения боли. Среди них – 69 мужчин и 87 женщин. Вторая группа, которая получала только фармакотерапию неопиоидными и опиоидными анальгетиками, включала 74 пациента, среди которых 30 мужчин и 44 женщины. Функциональный статус оценивали по шкале Карновского в %, интенсивность боли оценивали по нумерологической оценочной шкале от 0 до 10 (NRS), сокращение объема потребления анальгетиков оценивали по шкале Watkins scale. Общая удовлетворенность от лечения у пациентов и врачей оценивалась по шкале Лайкерта.
Результаты. В группе ИРЧА у 124 (79,5%) больных из 156 терапия оказалась эффективной в виде снижения NRS как минимум на 50% и снижения как минимум на 1 балл по Watkins scale. Функциональный статус улучшился как минимум на 10% по индексу Карновского у 121 (77,6%) больного. В контрольной группе эффективность фармакотерапии на основании NRS достигнута у 65 (87,8%) пациентов из 74, а общий соматический статус – у 60 (81,1%) пациентов. Максимальный обезболивающий эффект применения ИРЧА нервного корешка достигается на 10-е сутки после процедуры и остается стабильным до 90 сут. Уровень статистической значимости составил p<0,001. В группе ИРЧА у 153 (98,01%) больных не отмечалось осложнений, в контрольной группе осложнения отмечены в 64 (86,5%) случаях, проявлялись в виде неблагоприятных явлений от используемых для контроля боли анальгетиков. Исходно до начала исследования все 100% пациентов в обеих группах отмечали неудовлетворенность терапией боли до обращения к вертебрологу. Доля неудовлетворительных оценок по шкале Лайкерта при проведении лечения в группе ИРЧА уменьшилась до 20,5% (32 пациента), а в группе фармакотерапии – до 28,4% (21 пациент) соответственно.
Заключение. ИРЧА нервных корешков представляет собой высокоэффективный и безопасный малоинвазивный нейромодулирующий метод лечения боли у онкологических пациентов с компрессией нервных корешков, вызванной метастазами в позвоночнике. Этот метод позволяет в короткие сроки снизить или уменьшить выраженность болевого синдрома у 79,5% больных, что способствует повышению их физической активности и улучшает качество жизни, снижает неблагоприятные явления, обусловленные системным приемом анальгетиков, у 77,6% пациентов. ИРЧА нервных корешков имеет преимущества по сравнению с консервативным лечением в различных аспектах: снижение интенсивности болевого синдрома, повышение удовлетворенности пациентов результатами лечения, существенное уменьшение фармакологической нагрузки и связанных с ней осложнений, улучшение физической активности и качества жизни пациентов.
Ключевые слова: вертебральная онкология, онкологическая боль, фармакотерапия боли, костные метастазы, региональная анестезия, лучевая терапия, чрескожная вертебропластика, нейролизис, импульсная радиочастотная аблация, нейромодуляция
Материалы и методы. В работе проводился анализ данных 230 пациентов с болевым синдромом, связанным с метастатическим поражением позвоночника, участники распределены на две группы. В 1-ю группу включены 156 пациентов, которым проведена ИРЧА нервных корешков в целях облегчения боли. Среди них – 69 мужчин и 87 женщин. Вторая группа, которая получала только фармакотерапию неопиоидными и опиоидными анальгетиками, включала 74 пациента, среди которых 30 мужчин и 44 женщины. Функциональный статус оценивали по шкале Карновского в %, интенсивность боли оценивали по нумерологической оценочной шкале от 0 до 10 (NRS), сокращение объема потребления анальгетиков оценивали по шкале Watkins scale. Общая удовлетворенность от лечения у пациентов и врачей оценивалась по шкале Лайкерта.
Результаты. В группе ИРЧА у 124 (79,5%) больных из 156 терапия оказалась эффективной в виде снижения NRS как минимум на 50% и снижения как минимум на 1 балл по Watkins scale. Функциональный статус улучшился как минимум на 10% по индексу Карновского у 121 (77,6%) больного. В контрольной группе эффективность фармакотерапии на основании NRS достигнута у 65 (87,8%) пациентов из 74, а общий соматический статус – у 60 (81,1%) пациентов. Максимальный обезболивающий эффект применения ИРЧА нервного корешка достигается на 10-е сутки после процедуры и остается стабильным до 90 сут. Уровень статистической значимости составил p<0,001. В группе ИРЧА у 153 (98,01%) больных не отмечалось осложнений, в контрольной группе осложнения отмечены в 64 (86,5%) случаях, проявлялись в виде неблагоприятных явлений от используемых для контроля боли анальгетиков. Исходно до начала исследования все 100% пациентов в обеих группах отмечали неудовлетворенность терапией боли до обращения к вертебрологу. Доля неудовлетворительных оценок по шкале Лайкерта при проведении лечения в группе ИРЧА уменьшилась до 20,5% (32 пациента), а в группе фармакотерапии – до 28,4% (21 пациент) соответственно.
Заключение. ИРЧА нервных корешков представляет собой высокоэффективный и безопасный малоинвазивный нейромодулирующий метод лечения боли у онкологических пациентов с компрессией нервных корешков, вызванной метастазами в позвоночнике. Этот метод позволяет в короткие сроки снизить или уменьшить выраженность болевого синдрома у 79,5% больных, что способствует повышению их физической активности и улучшает качество жизни, снижает неблагоприятные явления, обусловленные системным приемом анальгетиков, у 77,6% пациентов. ИРЧА нервных корешков имеет преимущества по сравнению с консервативным лечением в различных аспектах: снижение интенсивности болевого синдрома, повышение удовлетворенности пациентов результатами лечения, существенное уменьшение фармакологической нагрузки и связанных с ней осложнений, улучшение физической активности и качества жизни пациентов.
Ключевые слова: вертебральная онкология, онкологическая боль, фармакотерапия боли, костные метастазы, региональная анестезия, лучевая терапия, чрескожная вертебропластика, нейролизис, импульсная радиочастотная аблация, нейромодуляция
________________________________________________
Aim. The objective of the study is to evaluate the clinical efficacy and safety of PRFA (pulsed radiofrequency ablation) of nerve roots in improving general somatic and functional status (Karnofsky score), decreasing pain (NRS) and reducing analgesics consumption (Watkins score) in patients with spine metastatic lesions.
Materials and methods. This study involved the analysis of 230 patients with pain syndrome related to metastatic lesions in the spine. Those patients were divided into two groups. The first group included 156 patients who underwent Pulsed RFA of nerve roots in order to relieve pain. There were 69 men and 87 women. The second group, which received only drug treatment with non-opioid and opioid analgesics, consisted of 74 patients, including 30 men and 44 women. The performance status was evaluated with the Karnofsky score (%), pain degree was assessed with the Numerical Rating Scale from 0 to 10 (NRS), and analgesics consumption reduction was assessed by the Watkins scale. Overall treatment satisfaction in patients and physicians was evaluated with the Likert scale.
Results. In the pulsed RFA group, 124 (79.5%) patients out of 156 had effective therapy in the form of NRS decrease of at least 50% and at least 1 point decrease by the Watkins scale. The performance status improved by at least 10% according to the Karnofsky index in 121 (77.6%) patients. As for the control group, the effectiveness of pharmacotherapy based on NRS was achieved in 65 (87.8%) out of 74 patients, and the general somatic status was improved in 60 (81.1%) patients. The maximum analgesic effect of the nerve root RFA is achieved on the 10th day after the procedure, maintaining for up to 90 days without dynamics. The level of statistical significance was p<0.001. In the RFA group, 153 (98.01%) patients experienced no complications, and in the control group, complications were seen in 64 (86.5%) cases, manifested themselves in the form of adverse events from analgesics used for pain control. Originally, prior to the study, all 100% of patients in both groups expressed pain therapy dissatisfaction before consulting a vertebrologist. The unsatisfactory score proportion on the Likert scale during the treatment in the RFA group decreased to 20.5% (32), and in the pharmacotherapy group – to 28.4% (21), respectively.
Conclusion. Pulsed radiofrequency ablation of nerve roots is highly effective and safe, minimally invasive neuromodulatory method for pain treatment in cancer patients with nerve roots compression caused by the spine metastases. This method allows within a short period to reduce or decrease the severity of pain syndrome in 79.5% of patients, contributing to their physical activity increase and improving the quality of life in 77.6% of patients. Pulsed RFA of nerve roots has advantages over conservative treatment in various aspects: decrease in pain syndrome intensity, enhanced patients satisfaction with treatment results, significant pharmacological stress and its associated complications reduction, improved patients physi-cal activity and quality of life.
Keywords: vertebral oncology, cancer pain, pharmacotherapy of pain, bone metastases, regional anesthesia, radiation therapy, percutaneous vertebroplasty, neurolysis, pulsed radiofrequency ablation, neuromodulation
Полный текст
Список литературы
1. Валиев А.К. Метастатические опухоли позвоночника. Современные возможности диагностики, индивидуальное прогнозирование, персонализация лечения: дис. … д-ра мед. наук. М. 2022 [Valiev AK. Metastaticheskiye opukholi pozvonochnika. Sovremennyie vozmozhnosti diagnostiki, individualnoie prognozirovaniie, personalizatsiia lecheniia: dis. … d-ra med. nauk. Moscow. 2022 (in Russian)].
2. Du ZY, Jie Z, Xiao-Dong T. Experts’ agreement on therapy for bone metastases. Orthop Surg. 2010;4(2):241-53.
3. Liu YH, Hu YCh, Yang XG, et al. Prognostic Factors of Ambulatory Status for Patients with Metastatic Spinal Cord Compression: A Systematic Review and Meta-Analysis. World Neurosurg. 2018;116:e278-90.
4. Patel P, Mehendiratta D, Bhambhu V, Dalvie S. Clinical outcome of intradural extramedullary spinal cord tumors: A single-center retrospective analytical study. Surg Neurol Int. 2021;12.
5. Yáñez ML, Miller JJ, Batchelor TT. Diagnosis and treatment of epidural metastases. Cancer. 2017;123(7):1106-14.
6. Лечение метастатического поражения позвоночника. Клинические рекомендации. M. 2018 [Lecheniie metastaticheskogo porazheniia pozvonochnika. Klinicheskiie rekomendatsii. Moscow. 2018 (in Russian)].
7. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:20 PART 2.
8. Coleman RE, Croucher PI, Padhani AR, et al. Bone metastases. Nat Rev Dis Prim. 2020;6:1.
9. Di Martino A, Caldaria A, De Vivo V, Denaro V. Metastatic epidural spinal cord compression. Exp Rev Anticancer Ther. 2016;16(11):1189-98.
10. Bona LG, Geleta D, Dulla D, et al. Economic Burden of Cancer on Cancer Patients Treated at Hawassa University Comprehensive Specialized Hospital. Cancer Control. 2021;28.
11. Косоруков В.С., Абузарова Г.Р., Захарочкина Е.Р., и др. Тафалгин – отечественный инновационный тетрапептидный препарат для подкожного введения: обзор результатов клинических исследований I и II фаз. Опухоли головы и шеи. 2022;12(2):89-107 [Kosorukov VS, Abuzarova GR, Zakharochkina ER, et al. Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials. Head and Neck Tumors. 2022;12(2):89-107 (in Russian)].
12. Исакова М.Е. Болевой синдром в онкологии. M. 2011 [Isakova ME. Bolevoi sindrom v onkologii. Moscow. 2011 (in Russian)].
13. Ткачев С.Ю., Кит О.И., Максимов А.Ю., и др. Модели болевого синдрома в экспериментальной онкологии. Современные проблемы науки и образования. 2020;(1):94 [Tkachev SIu, Kit OI, Maksimov AIu, et al. Modeli bolevogo sindroma v eksperimentalnoi onkologii. Sovremennyie Problemy Nauki i Obrazovaniia. 2020;(1):94 (in Russian)].
14. Burma NE, Leduc-Pessah H, Fan CY, Trang T. Animal models of chronic pain: Advances and challenges for clinical translation. J Neurosci Res. 2017;95(6):1242-56.
15. Kuner R, Flor H. Structural plasticity and reorganisation in chronic pain. Nat Rev Neurosci. 2016;18(1):20-30.
16. Swarm RA, Youngwerth JM, Agne JL, et al. NCCN Guidelines Version 1.2022 Adult Cancer Pain Continue NCCN Guidelines Panel Disclosures. 2022.
17. Арсеньев А., Канаев С., Новиков С., и др. Стереотаксическая лучевая терапия в лечении первичных и метастатических опухолевых поражений позвоночника. Вопросы онкологии. 2022;4(68):413-26 [Arseniev A, Kanaev S, Novikov S, et al. Stereotaksicheskaia luchevaia terapiia v lechenii pervichnykh i metastaticheskikh opukholevykh porazhenii pozvonochnika. Voprosy Onkologii. 2022;4(68):413-26 (in Russian)].
18. Chow R, Hoskin P, Chan S, et al. Efficacy of multiple fraction conventional radiation therapy for painful uncomplicated bone metastases: A systematic review. Radiother Oncol. 2017;122(3):323-31.
19. Хмелевский Е.В., Бычкова Н.М. Эффективность лучевой терапии костных метастазов рака шейки и тела матки. Онкология. Журнал им. П.А. Герцена. 2020;9(3):5-9 [Khmelevsky EV, Bychkova NM. Effectiveness of radiation therapy for bone metastases of cervical and uterine cancer. P.A. Herzen Journal of Oncology. 2020;9(3):5-9 (in Russian)].
20. Lutz S, Balboni T, Joshua Jones J, et al. Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol. 2017;1(7):4-12.
21. Абузарова Г.Р. Лечение хронической боли у онкологических пациентов. В кн.: Национальное руководство по паллиативной медицинской помощи в онкологии. Под ред. проф. А.Д. Каприна. М. 2022 [Abuzarova GR. Lechenie khronicheskoш boli u onkologicheskikh patsientov. V kn.: Natsionalnoe rukovodstvo po palliativnoш meditsinskoш pomoshchi v onkologii. Pod red. prof. AD Kaprina. Moscow. 2022 (in Russian)].
22. Зырянов С.К., Затолочина К.Э. Перспективы применения радионуклидных лекарственных препаратов при лечении злокачественных новообразований в РФ. Качественная клиническая практика. 2018;2:51-7 [Zyryanov SK, Zatolochina KE. Perspective for use of the radionuclide drugs in the treatment of malignant tumors in Russia. Good Clinical Practice. 2018;2:51-7 (in Russian)].
23. Chow E, Zeng L, Salvo N, et al. Update on the Systematic Review of Palliative Radiotherapy Trials for Bone Metastases. Clin Oncol. 2012;2(24):112-24.
24. Hoskin P, Rojas A, Fidarova E, et al. IAEA randomised trial of optimal single dose radiotherapy in the treatment of painful bone metastases. Radiother Oncol. 2015;1(116):10-4.
25. Choi D, Crockard A, Bunger C, et al. Review of metastatic spine tumour classification and indications for surgery: The consensus statement of the Global Spine Tumour Study Group. Eur Spine J. 2010;19(2):215-22.
26. Klimo P Jr, Thompson CJ, Kestle JR, Schmidt MH. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro-Oncol. 2005;1(7):64-76.
27. Galgano M, Fridley J, Oyelese A, et al. Surgical management of spinal metastases. Exp Rev Anticancer Ther. 2018;18(5):463-72.
28. Gumusay O, Huppert LA, Behr SC, Rugo HS. The role of percutaneous vertebral augmentation in patients with metastatic breast cancer: Literature review including report of two cases. Breast. 2022;63:149-56.
29. Stephenson MB, Glaenzer B, Malamis A. Percutaneous Minimally Invasive Techniques in the Treatment of Spinal Metastases. Curr Treat Option Oncol. 2016;17:11.
30. Filippiadis DK, Cornelis FH, Kelekis A. Interventional oncologic procedures for pain palliation. Presse Med. 2019;48(7-8P2):e251-6.
31. Allano G, George B, Minello C, et al. Strategies for interventional therapies in cancer-related pain – a crossroad in cancer pain management. Support Care Cancer. 2019;27;8:3133-45.
32. Бондаренко С.Ю., Гуреев А.Д., Труханова И.Г. Клинический случай применения имплантируемой спинальной порт-системы. Казанский медицинский журнал. 2020;101(2):271-4 [Bondarenko SY, Gureev AD, Trukhanov IG. Clinical case of using of implantable spinal access port system. Kazan Medical Journal. 2020;101(2):271-4 (in Russian)].
33. Filippiadis DK, Tselikas L, Tsitskari M, et al. Percutaneous Neurolysis for Pain Management in Oncological Patients. CardioVasc Intervent Radiol. 2019;42(6):791-9.
34. Yarikov A, Kuznetsov S, Dubskikh A, et al. Modern approaches in the treatment of oncological pain: interventional treatment. Bone and Soft Tissue Sarcomas Tumors of the Skin. 2022;3(14):57-69.
35. Yarikov A, Kuznetsov S, Dubskikh A, et al. Modern approaches in the treatment of oncological pain: surgical treatment. Bone and Soft Tissue Sarcomas Tumors of the Skin. 2023;1(15):17-27.
36. Shepherd TM, Hoch MJ, Cohen BA, et al. Palliative CT-guided cordotomy for medically intractable pain in patients with cancer. Am J Neuroradiol. 2017;2(38):387-90.
37. Arai YC, Nishihara M, Yamamoto Y, et al. Dorsal root ganglion pulsed radiofrequency for the management of intractable vertebral metastatic pain: a case series. Pain Med. 2015;7(16):1007-12.
38. Fanous SN, Saleh EG, Abd Elghafar EM, Ghobrial HZ. Randomized controlled trials between dorsal root ganglion thermal radiofrequency and pulsed radiofrequency for the management of intractable metastatic back pain in thoracic vertebral body. Br J Pain. 2021;3(15):270-81.
39. Wang F, Zhou Q, Xiao L, et al. A Randomized Comparative Study of Pulsed Radiofrequency Treatment With or Without Selective Nerve Root Block for Chronic Cervical Radicular Pain. Pain Pract. 2017;17(5):589-95.
40. Vanila M, Singh MD. The Pain Management Best Practices Inter-Agency Task Force (Task Force). 2019.
41. Vuka I, Marciuš T, Došenović S, et al. Efficacy and safety of pulsed radiofrequency as a method of dorsal root ganglia stimulation in patients with neuropathic pain: A systematic review. Pain Med. 2020;21(12):3320-43.
42. Nishihara M, Arai YC, Yamamoto Y, et al. Randomized Trial Combinations of Low-Dose Antidepressants and Low-Dose Pregabalin as Useful Adjuvants to Opioids for Intractable. Painful Bone Metast. 2013;16(5):E547-52.
43. Watkins RG, O'Brien JP, Draugelis R, Jones D. Comparisons of preoperative and postoperative MMPI data in chronic back patients. Spine (Phila Pa 1976). 1986;11(4):385-90. DOI:10.1097/00007632-198605000-00018
44. Бикмуллин В.Н., Клиценко О.А., Руденко В.В. Сравнительный анализ шкал оценки экономического и функционального статуса D. Prolo и R. Watkins. Российский нейрохирургический журнал имени профессора А.Л. Поленова. 2015;3(7):5-10 [Bikmullin VN, Klitsenko OA, Rudenko VV. Comparative analysis of Prolo and Watkins scales evaluating economic and functional status. Rossiiskii Neyrokhirurgicheskii Zhurnal imeni Professora AL Polenova. 2015;3(7):5-10 (in Russian)].
45. Гуща А.О., Юсупова А.Р. Оценка исходов хирургического лечения дегенеративно-дистрофических заболеваний позвоночника. Хирургия позвоночника. 2017;14(4):85-94 [Gushcha AO, Yusupova AR. Evaluation of outcomes of surgical treatment for degenerative diseases of the spine. Russian Journal of Spine Surgery. 2017;14(4):85-94 (in Russian)].
46. Carlson CL. Effectiveness of the World Health Organization cancer pain relief guidelines: An integrative review. J Pain Res. 2016;9:515-34.
47. Chun EH, Kim YJ, Woo JH. Which is your choice for prolonging the analgesic duration of single-shot interscalene brachial blocks for arthroscopic shoulder surgery? intravenous dexamethasone 5mg vs. perineural dexamethasone 5mg randomized, controlled, clinical trial. Medicine. 2016;23(95).
48. Ruppert LM, Reilly J. Metastatic spine oncology: Symptom-directed management. Neuro-Oncol Pract. 2020;7:I54-61.
49. Schneider G, Voltz R, Gaertner J. Cancer pain management and bone metastases: An update for the clinician. Breast Care. 2012;7(2):113-20.
50. Steven D. Waldman Atlas of Interventional Pain Management. 2021.
51. Waldron NH, Jones CA, Gan TJ, et al. Impact of perioperative dexamethasone on postoperative analgesia and side-effects: Systematic review and meta-analysis. Br J Anaesthesia. 2013;110(2):191-200.
52. Cosman ER Jr, Cosman ER Sr. Electric and Thermal Field Effects in Tissue Around Radiofrequency Electrodes. Pain Med. 2005;6(6):405-24.
53. Deer TR, Azeem N. Essentials of Radiofrequency Ablation of the Spine and Joints. 2021.
54. Podhajsky RJ, Sekiguchi Y, Kikuchi S, Myers RR. The Histologic Effects of Pulsed and Continuous Radiofrequency Lesions at 42°C to Rat Dorsal Root Ganglion and Sciatic Nerve. Spine. 2005;9(30):1008-13.
55. Sluijter ME, Cosman E, Rittman I. The effects of pulsed radiofrequency fi eld applied to the dorsal root ganglion: a preliminary report. Pain Clin. 1998;11:109-17.
56. Arai YC, Nishihara M, Aono S, et al. Pulsed radiofrequency treatment within brachial plexus for the management of intractable neoplastic plexopathic pain. J Anesthesia. 2013;2(27):298-301.
57. Van Boxem K, van Eerd M, Brinkhuizen T, et al. Radiofrequency and pulsed radiofrequency treatment of chronic pain syndromes: The available evidence. Pain Pract. 2008;5(8):385-93.
58. Munglani R. The longer term effect of pulsed radiofrequency for neuropathic pain. Pain. 1999;80(1-2):437-9. DOI:10.1016/s0304-3959(98)00183-3
59. Dowdall T, Robinson I, Meert TF. Comparison of five different rat models of peripheral nerve injury. Pharmacol Biochem Behav. 2005;1(80):93-108.
60. Sandkühler J, Chen JG, Cheng G, Randić M. Low-Frequency Stimulation of Afferent A-Fibers Induces Long-Term Depression at Primary Afferent Synapses with Substantia Gelatinosa. J Neurosci. 1997;17(16):6483-91.
61. Hetta DF, Mohamed AA, Abdel Eman RM, et al. Pulsed Radiofrequency of the Sacral Roots Improves the Success Rate of Superior Hypogastric Plexus Neurolysis in Controlling Pelvic and Perineal Cancer Pain. Randomized Trial. Pain Physic. 2020;23:149-57.
62. Ren H, Jin H, Jia Z, et al. Pulsed radiofrequency applied to the sciatic nerve improves neuropathic pain by down-regulating the expression of calcitonin gene-related peptide in the dorsal root ganglion. Int J Med Sci. 2018;2(15):153-60.
63. Fu M, Meng L, Ren H, Luo F. Pulsed radiofrequency inhibits expression of P2X3receptors and alleviates neuropathic pain induced by chronic constriction injury in rats. Chin Med J. 2019;14(132):1706-12.
64. Jiang R, Li P, Yao YX, et al. Pulsed radiofrequency to the dorsal root ganglion or the sciatic nerve reduces neuropathic pain behavior, decreases peripheral pro-inflammatory cytokines and spinal β-catenin in chronic constriction injury rats. Regional Anesthesia Pain Med. 2019;7(44):742-6.
65. Vallejo R, Tilley DM, Williams J, et al. Randomized Controlled Trial Pulsed Radiofrequency Modulates Pain Regulatory Gene Expression Along the Nociceptive Pathway. Pain Physician. 2013;16:601-13.
66. Hailong J, Hao R, Zipu J, et al. Pulsed radiofrequency improves neuropathic pain in chronic constriction injury rats through the upregulation of the transcription and translation levels of glial cell line-derived neurotrophic factor. Pain Physician. 2018;21:33-40.
67. Jia Z, Ren H, Li Q, et al. Pulsed Radiofrequency Reduced Neuropathic Pain Behavior in Rats Associated with Upregulation of GDNF Expression. Pain Physician. 2016;19:49-58.
68. Liu CK, Liao WT, Chu YC, et al. Pulsed Radiofrequency Attenuates Complete Freund’s Adjuvant-Induced Epigenetic Suppression of Potassium Chloride Cotransporter 2 Expression. Pain Med. 2017;4(18):807-13.
69. Choi D, Crockard A, Bunger C, et al. Review of metastatic spine tumour classification and indications for surgery: The consensus statement of the Global Spine Tumour Study Group. Eur Spine J. 2010;19;2:215-22.
70. Murali N, Turmezei T, Bhatti S, et al. What is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? A systematic review and meta-analysis. J Orthopaed Surg Res. 2021;16:1.
2. Du ZY, Jie Z, Xiao-Dong T. Experts’ agreement on therapy for bone metastases. Orthop Surg. 2010;4(2):241-53.
3. Liu YH, Hu YCh, Yang XG, et al. Prognostic Factors of Ambulatory Status for Patients with Metastatic Spinal Cord Compression: A Systematic Review and Meta-Analysis. World Neurosurg. 2018;116:e278-90.
4. Patel P, Mehendiratta D, Bhambhu V, Dalvie S. Clinical outcome of intradural extramedullary spinal cord tumors: A single-center retrospective analytical study. Surg Neurol Int. 2021;12.
5. Yáñez ML, Miller JJ, Batchelor TT. Diagnosis and treatment of epidural metastases. Cancer. 2017;123(7):1106-14.
6. Лечение метастатического поражения позвоночника. Клинические рекомендации. M. 2018 [Lecheniie metastaticheskogo porazheniia pozvonochnika. Klinicheskiie rekomendatsii. Moscow. 2018 (in Russian)].
7. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:20 PART 2.
8. Coleman RE, Croucher PI, Padhani AR, et al. Bone metastases. Nat Rev Dis Prim. 2020;6:1.
9. Di Martino A, Caldaria A, De Vivo V, Denaro V. Metastatic epidural spinal cord compression. Exp Rev Anticancer Ther. 2016;16(11):1189-98.
10. Bona LG, Geleta D, Dulla D, et al. Economic Burden of Cancer on Cancer Patients Treated at Hawassa University Comprehensive Specialized Hospital. Cancer Control. 2021;28.
11. Косоруков В.С., Абузарова Г.Р., Захарочкина Е.Р., и др. Тафалгин – отечественный инновационный тетрапептидный препарат для подкожного введения: обзор результатов клинических исследований I и II фаз. Опухоли головы и шеи. 2022;12(2):89-107 [Kosorukov VS, Abuzarova GR, Zakharochkina ER, et al. Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials. Head and Neck Tumors. 2022;12(2):89-107 (in Russian)].
12. Исакова М.Е. Болевой синдром в онкологии. M. 2011 [Isakova ME. Bolevoi sindrom v onkologii. Moscow. 2011 (in Russian)].
13. Ткачев С.Ю., Кит О.И., Максимов А.Ю., и др. Модели болевого синдрома в экспериментальной онкологии. Современные проблемы науки и образования. 2020;(1):94 [Tkachev SIu, Kit OI, Maksimov AIu, et al. Modeli bolevogo sindroma v eksperimentalnoi onkologii. Sovremennyie Problemy Nauki i Obrazovaniia. 2020;(1):94 (in Russian)].
14. Burma NE, Leduc-Pessah H, Fan CY, Trang T. Animal models of chronic pain: Advances and challenges for clinical translation. J Neurosci Res. 2017;95(6):1242-56.
15. Kuner R, Flor H. Structural plasticity and reorganisation in chronic pain. Nat Rev Neurosci. 2016;18(1):20-30.
16. Swarm RA, Youngwerth JM, Agne JL, et al. NCCN Guidelines Version 1.2022 Adult Cancer Pain Continue NCCN Guidelines Panel Disclosures. 2022.
17. Арсеньев А., Канаев С., Новиков С., и др. Стереотаксическая лучевая терапия в лечении первичных и метастатических опухолевых поражений позвоночника. Вопросы онкологии. 2022;4(68):413-26 [Arseniev A, Kanaev S, Novikov S, et al. Stereotaksicheskaia luchevaia terapiia v lechenii pervichnykh i metastaticheskikh opukholevykh porazhenii pozvonochnika. Voprosy Onkologii. 2022;4(68):413-26 (in Russian)].
18. Chow R, Hoskin P, Chan S, et al. Efficacy of multiple fraction conventional radiation therapy for painful uncomplicated bone metastases: A systematic review. Radiother Oncol. 2017;122(3):323-31.
19. Хмелевский Е.В., Бычкова Н.М. Эффективность лучевой терапии костных метастазов рака шейки и тела матки. Онкология. Журнал им. П.А. Герцена. 2020;9(3):5-9 [Khmelevsky EV, Bychkova NM. Effectiveness of radiation therapy for bone metastases of cervical and uterine cancer. P.A. Herzen Journal of Oncology. 2020;9(3):5-9 (in Russian)].
20. Lutz S, Balboni T, Joshua Jones J, et al. Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol. 2017;1(7):4-12.
21. Абузарова Г.Р. Лечение хронической боли у онкологических пациентов. В кн.: Национальное руководство по паллиативной медицинской помощи в онкологии. Под ред. проф. А.Д. Каприна. М. 2022 [Abuzarova GR. Lechenie khronicheskoш boli u onkologicheskikh patsientov. V kn.: Natsionalnoe rukovodstvo po palliativnoш meditsinskoш pomoshchi v onkologii. Pod red. prof. AD Kaprina. Moscow. 2022 (in Russian)].
22. Зырянов С.К., Затолочина К.Э. Перспективы применения радионуклидных лекарственных препаратов при лечении злокачественных новообразований в РФ. Качественная клиническая практика. 2018;2:51-7 [Zyryanov SK, Zatolochina KE. Perspective for use of the radionuclide drugs in the treatment of malignant tumors in Russia. Good Clinical Practice. 2018;2:51-7 (in Russian)].
23. Chow E, Zeng L, Salvo N, et al. Update on the Systematic Review of Palliative Radiotherapy Trials for Bone Metastases. Clin Oncol. 2012;2(24):112-24.
24. Hoskin P, Rojas A, Fidarova E, et al. IAEA randomised trial of optimal single dose radiotherapy in the treatment of painful bone metastases. Radiother Oncol. 2015;1(116):10-4.
25. Choi D, Crockard A, Bunger C, et al. Review of metastatic spine tumour classification and indications for surgery: The consensus statement of the Global Spine Tumour Study Group. Eur Spine J. 2010;19(2):215-22.
26. Klimo P Jr, Thompson CJ, Kestle JR, Schmidt MH. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro-Oncol. 2005;1(7):64-76.
27. Galgano M, Fridley J, Oyelese A, et al. Surgical management of spinal metastases. Exp Rev Anticancer Ther. 2018;18(5):463-72.
28. Gumusay O, Huppert LA, Behr SC, Rugo HS. The role of percutaneous vertebral augmentation in patients with metastatic breast cancer: Literature review including report of two cases. Breast. 2022;63:149-56.
29. Stephenson MB, Glaenzer B, Malamis A. Percutaneous Minimally Invasive Techniques in the Treatment of Spinal Metastases. Curr Treat Option Oncol. 2016;17:11.
30. Filippiadis DK, Cornelis FH, Kelekis A. Interventional oncologic procedures for pain palliation. Presse Med. 2019;48(7-8P2):e251-6.
31. Allano G, George B, Minello C, et al. Strategies for interventional therapies in cancer-related pain – a crossroad in cancer pain management. Support Care Cancer. 2019;27;8:3133-45.
32. Бондаренко С.Ю., Гуреев А.Д., Труханова И.Г. Клинический случай применения имплантируемой спинальной порт-системы. Казанский медицинский журнал. 2020;101(2):271-4 [Bondarenko SY, Gureev AD, Trukhanov IG. Clinical case of using of implantable spinal access port system. Kazan Medical Journal. 2020;101(2):271-4 (in Russian)].
33. Filippiadis DK, Tselikas L, Tsitskari M, et al. Percutaneous Neurolysis for Pain Management in Oncological Patients. CardioVasc Intervent Radiol. 2019;42(6):791-9.
34. Yarikov A, Kuznetsov S, Dubskikh A, et al. Modern approaches in the treatment of oncological pain: interventional treatment. Bone and Soft Tissue Sarcomas Tumors of the Skin. 2022;3(14):57-69.
35. Yarikov A, Kuznetsov S, Dubskikh A, et al. Modern approaches in the treatment of oncological pain: surgical treatment. Bone and Soft Tissue Sarcomas Tumors of the Skin. 2023;1(15):17-27.
36. Shepherd TM, Hoch MJ, Cohen BA, et al. Palliative CT-guided cordotomy for medically intractable pain in patients with cancer. Am J Neuroradiol. 2017;2(38):387-90.
37. Arai YC, Nishihara M, Yamamoto Y, et al. Dorsal root ganglion pulsed radiofrequency for the management of intractable vertebral metastatic pain: a case series. Pain Med. 2015;7(16):1007-12.
38. Fanous SN, Saleh EG, Abd Elghafar EM, Ghobrial HZ. Randomized controlled trials between dorsal root ganglion thermal radiofrequency and pulsed radiofrequency for the management of intractable metastatic back pain in thoracic vertebral body. Br J Pain. 2021;3(15):270-81.
39. Wang F, Zhou Q, Xiao L, et al. A Randomized Comparative Study of Pulsed Radiofrequency Treatment With or Without Selective Nerve Root Block for Chronic Cervical Radicular Pain. Pain Pract. 2017;17(5):589-95.
40. Vanila M, Singh MD. The Pain Management Best Practices Inter-Agency Task Force (Task Force). 2019.
41. Vuka I, Marciuš T, Došenović S, et al. Efficacy and safety of pulsed radiofrequency as a method of dorsal root ganglia stimulation in patients with neuropathic pain: A systematic review. Pain Med. 2020;21(12):3320-43.
42. Nishihara M, Arai YC, Yamamoto Y, et al. Randomized Trial Combinations of Low-Dose Antidepressants and Low-Dose Pregabalin as Useful Adjuvants to Opioids for Intractable. Painful Bone Metast. 2013;16(5):E547-52.
43. Watkins RG, O'Brien JP, Draugelis R, Jones D. Comparisons of preoperative and postoperative MMPI data in chronic back patients. Spine (Phila Pa 1976). 1986;11(4):385-90. DOI:10.1097/00007632-198605000-00018
44. Бикмуллин В.Н., Клиценко О.А., Руденко В.В. Сравнительный анализ шкал оценки экономического и функционального статуса D. Prolo и R. Watkins. Российский нейрохирургический журнал имени профессора А.Л. Поленова. 2015;3(7):5-10 [Bikmullin VN, Klitsenko OA, Rudenko VV. Comparative analysis of Prolo and Watkins scales evaluating economic and functional status. Rossiiskii Neyrokhirurgicheskii Zhurnal imeni Professora AL Polenova. 2015;3(7):5-10 (in Russian)].
45. Гуща А.О., Юсупова А.Р. Оценка исходов хирургического лечения дегенеративно-дистрофических заболеваний позвоночника. Хирургия позвоночника. 2017;14(4):85-94 [Gushcha AO, Yusupova AR. Evaluation of outcomes of surgical treatment for degenerative diseases of the spine. Russian Journal of Spine Surgery. 2017;14(4):85-94 (in Russian)].
46. Carlson CL. Effectiveness of the World Health Organization cancer pain relief guidelines: An integrative review. J Pain Res. 2016;9:515-34.
47. Chun EH, Kim YJ, Woo JH. Which is your choice for prolonging the analgesic duration of single-shot interscalene brachial blocks for arthroscopic shoulder surgery? intravenous dexamethasone 5mg vs. perineural dexamethasone 5mg randomized, controlled, clinical trial. Medicine. 2016;23(95).
48. Ruppert LM, Reilly J. Metastatic spine oncology: Symptom-directed management. Neuro-Oncol Pract. 2020;7:I54-61.
49. Schneider G, Voltz R, Gaertner J. Cancer pain management and bone metastases: An update for the clinician. Breast Care. 2012;7(2):113-20.
50. Steven D. Waldman Atlas of Interventional Pain Management. 2021.
51. Waldron NH, Jones CA, Gan TJ, et al. Impact of perioperative dexamethasone on postoperative analgesia and side-effects: Systematic review and meta-analysis. Br J Anaesthesia. 2013;110(2):191-200.
52. Cosman ER Jr, Cosman ER Sr. Electric and Thermal Field Effects in Tissue Around Radiofrequency Electrodes. Pain Med. 2005;6(6):405-24.
53. Deer TR, Azeem N. Essentials of Radiofrequency Ablation of the Spine and Joints. 2021.
54. Podhajsky RJ, Sekiguchi Y, Kikuchi S, Myers RR. The Histologic Effects of Pulsed and Continuous Radiofrequency Lesions at 42°C to Rat Dorsal Root Ganglion and Sciatic Nerve. Spine. 2005;9(30):1008-13.
55. Sluijter ME, Cosman E, Rittman I. The effects of pulsed radiofrequency fi eld applied to the dorsal root ganglion: a preliminary report. Pain Clin. 1998;11:109-17.
56. Arai YC, Nishihara M, Aono S, et al. Pulsed radiofrequency treatment within brachial plexus for the management of intractable neoplastic plexopathic pain. J Anesthesia. 2013;2(27):298-301.
57. Van Boxem K, van Eerd M, Brinkhuizen T, et al. Radiofrequency and pulsed radiofrequency treatment of chronic pain syndromes: The available evidence. Pain Pract. 2008;5(8):385-93.
58. Munglani R. The longer term effect of pulsed radiofrequency for neuropathic pain. Pain. 1999;80(1-2):437-9. DOI:10.1016/s0304-3959(98)00183-3
59. Dowdall T, Robinson I, Meert TF. Comparison of five different rat models of peripheral nerve injury. Pharmacol Biochem Behav. 2005;1(80):93-108.
60. Sandkühler J, Chen JG, Cheng G, Randić M. Low-Frequency Stimulation of Afferent A-Fibers Induces Long-Term Depression at Primary Afferent Synapses with Substantia Gelatinosa. J Neurosci. 1997;17(16):6483-91.
61. Hetta DF, Mohamed AA, Abdel Eman RM, et al. Pulsed Radiofrequency of the Sacral Roots Improves the Success Rate of Superior Hypogastric Plexus Neurolysis in Controlling Pelvic and Perineal Cancer Pain. Randomized Trial. Pain Physic. 2020;23:149-57.
62. Ren H, Jin H, Jia Z, et al. Pulsed radiofrequency applied to the sciatic nerve improves neuropathic pain by down-regulating the expression of calcitonin gene-related peptide in the dorsal root ganglion. Int J Med Sci. 2018;2(15):153-60.
63. Fu M, Meng L, Ren H, Luo F. Pulsed radiofrequency inhibits expression of P2X3receptors and alleviates neuropathic pain induced by chronic constriction injury in rats. Chin Med J. 2019;14(132):1706-12.
64. Jiang R, Li P, Yao YX, et al. Pulsed radiofrequency to the dorsal root ganglion or the sciatic nerve reduces neuropathic pain behavior, decreases peripheral pro-inflammatory cytokines and spinal β-catenin in chronic constriction injury rats. Regional Anesthesia Pain Med. 2019;7(44):742-6.
65. Vallejo R, Tilley DM, Williams J, et al. Randomized Controlled Trial Pulsed Radiofrequency Modulates Pain Regulatory Gene Expression Along the Nociceptive Pathway. Pain Physician. 2013;16:601-13.
66. Hailong J, Hao R, Zipu J, et al. Pulsed radiofrequency improves neuropathic pain in chronic constriction injury rats through the upregulation of the transcription and translation levels of glial cell line-derived neurotrophic factor. Pain Physician. 2018;21:33-40.
67. Jia Z, Ren H, Li Q, et al. Pulsed Radiofrequency Reduced Neuropathic Pain Behavior in Rats Associated with Upregulation of GDNF Expression. Pain Physician. 2016;19:49-58.
68. Liu CK, Liao WT, Chu YC, et al. Pulsed Radiofrequency Attenuates Complete Freund’s Adjuvant-Induced Epigenetic Suppression of Potassium Chloride Cotransporter 2 Expression. Pain Med. 2017;4(18):807-13.
69. Choi D, Crockard A, Bunger C, et al. Review of metastatic spine tumour classification and indications for surgery: The consensus statement of the Global Spine Tumour Study Group. Eur Spine J. 2010;19;2:215-22.
70. Murali N, Turmezei T, Bhatti S, et al. What is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? A systematic review and meta-analysis. J Orthopaed Surg Res. 2021;16:1.
________________________________________________
1. Valiev AK. Metastaticheskiye opukholi pozvonochnika. Sovremennyie vozmozhnosti diagnostiki, individualnoie prognozirovaniie, personalizatsiia lecheniia: dis. … d-ra med. nauk. Moscow. 2022 (in Russian).
2. Du ZY, Jie Z, Xiao-Dong T. Experts’ agreement on therapy for bone metastases. Orthop Surg. 2010;4(2):241-53.
3. Liu YH, Hu YCh, Yang XG, et al. Prognostic Factors of Ambulatory Status for Patients with Metastatic Spinal Cord Compression: A Systematic Review and Meta-Analysis. World Neurosurg. 2018;116:e278-90.
4. Patel P, Mehendiratta D, Bhambhu V, Dalvie S. Clinical outcome of intradural extramedullary spinal cord tumors: A single-center retrospective analytical study. Surg Neurol Int. 2021;12.
5. Yáñez ML, Miller JJ, Batchelor TT. Diagnosis and treatment of epidural metastases. Cancer. 2017;123(7):1106-14.
6. Lecheniie metastaticheskogo porazheniia pozvonochnika. Klinicheskiie rekomendatsii. Moscow. 2018 (in Russian).
7. Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12:20 PART 2.
8. Coleman RE, Croucher PI, Padhani AR, et al. Bone metastases. Nat Rev Dis Prim. 2020;6:1.
9. Di Martino A, Caldaria A, De Vivo V, Denaro V. Metastatic epidural spinal cord compression. Exp Rev Anticancer Ther. 2016;16(11):1189-98.
10. Bona LG, Geleta D, Dulla D, et al. Economic Burden of Cancer on Cancer Patients Treated at Hawassa University Comprehensive Specialized Hospital. Cancer Control. 2021;28.
11. Kosorukov VS, Abuzarova GR, Zakharochkina ER, et al. Tafalgin is a Russian innovative tetrapeptide pharmaceutical for subcutaneous injection: review of the results of phase I and II clinical trials. Head and Neck Tumors. 2022;12(2):89-107 (in Russian).
12. Isakova ME. Bolevoi sindrom v onkologii. Moscow. 2011 (in Russian).
13. Tkachev SIu, Kit OI, Maksimov AIu, et al. Modeli bolevogo sindroma v eksperimentalnoi onkologii. Sovremennyie Problemy Nauki i Obrazovaniia. 2020;(1):94 (in Russian).
14. Burma NE, Leduc-Pessah H, Fan CY, Trang T. Animal models of chronic pain: Advances and challenges for clinical translation. J Neurosci Res. 2017;95(6):1242-56.
15. Kuner R, Flor H. Structural plasticity and reorganisation in chronic pain. Nat Rev Neurosci. 2016;18(1):20-30.
16. Swarm RA, Youngwerth JM, Agne JL, et al. NCCN Guidelines Version 1.2022 Adult Cancer Pain Continue NCCN Guidelines Panel Disclosures. 2022.
17. Arseniev A, Kanaev S, Novikov S, et al. Stereotaksicheskaia luchevaia terapiia v lechenii pervichnykh i metastaticheskikh opukholevykh porazhenii pozvonochnika. Voprosy Onkologii. 2022;4(68):413-26 (in Russian).
18. Chow R, Hoskin P, Chan S, et al. Efficacy of multiple fraction conventional radiation therapy for painful uncomplicated bone metastases: A systematic review. Radiother Oncol. 2017;122(3):323-31.
19. Khmelevsky EV, Bychkova NM. Effectiveness of radiation therapy for bone metastases of cervical and uterine cancer. P.A. Herzen Journal of Oncology. 2020;9(3):5-9 (in Russian).
20. Lutz S, Balboni T, Joshua Jones J, et al. Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol. 2017;1(7):4-12.
21. Abuzarova GR. Lechenie khronicheskoш boli u onkologicheskikh patsientov. V kn.: Natsionalnoe rukovodstvo po palliativnoш meditsinskoш pomoshchi v onkologii. Pod red. prof. AD Kaprina. Moscow. 2022 (in Russian).
22. Zyryanov SK, Zatolochina KE. Perspective for use of the radionuclide drugs in the treatment of malignant tumors in Russia. Good Clinical Practice. 2018;2:51-7 (in Russian).
23. Chow E, Zeng L, Salvo N, et al. Update on the Systematic Review of Palliative Radiotherapy Trials for Bone Metastases. Clin Oncol. 2012;2(24):112-24.
24. Hoskin P, Rojas A, Fidarova E, et al. IAEA randomised trial of optimal single dose radiotherapy in the treatment of painful bone metastases. Radiother Oncol. 2015;1(116):10-4.
25. Choi D, Crockard A, Bunger C, et al. Review of metastatic spine tumour classification and indications for surgery: The consensus statement of the Global Spine Tumour Study Group. Eur Spine J. 2010;19(2):215-22.
26. Klimo P Jr, Thompson CJ, Kestle JR, Schmidt MH. A meta-analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro-Oncol. 2005;1(7):64-76.
27. Galgano M, Fridley J, Oyelese A, et al. Surgical management of spinal metastases. Exp Rev Anticancer Ther. 2018;18(5):463-72.
28. Gumusay O, Huppert LA, Behr SC, Rugo HS. The role of percutaneous vertebral augmentation in patients with metastatic breast cancer: Literature review including report of two cases. Breast. 2022;63:149-56.
29. Stephenson MB, Glaenzer B, Malamis A. Percutaneous Minimally Invasive Techniques in the Treatment of Spinal Metastases. Curr Treat Option Oncol. 2016;17:11.
30. Filippiadis DK, Cornelis FH, Kelekis A. Interventional oncologic procedures for pain palliation. Presse Med. 2019;48(7-8P2):e251-6.
31. Allano G, George B, Minello C, et al. Strategies for interventional therapies in cancer-related pain – a crossroad in cancer pain management. Support Care Cancer. 2019;27;8:3133-45.
32. Bondarenko SY, Gureev AD, Trukhanov IG. Clinical case of using of implantable spinal access port system. Kazan Medical Journal. 2020;101(2):271-4 (in Russian).
33. Filippiadis DK, Tselikas L, Tsitskari M, et al. Percutaneous Neurolysis for Pain Management in Oncological Patients. CardioVasc Intervent Radiol. 2019;42(6):791-9.
34. Yarikov A, Kuznetsov S, Dubskikh A, et al. Modern approaches in the treatment of oncological pain: interventional treatment. Bone and Soft Tissue Sarcomas Tumors of the Skin. 2022;3(14):57-69.
35. Yarikov A, Kuznetsov S, Dubskikh A, et al. Modern approaches in the treatment of oncological pain: surgical treatment. Bone and Soft Tissue Sarcomas Tumors of the Skin. 2023;1(15):17-27.
36. Shepherd TM, Hoch MJ, Cohen BA, et al. Palliative CT-guided cordotomy for medically intractable pain in patients with cancer. Am J Neuroradiol. 2017;2(38):387-90.
37. Arai YC, Nishihara M, Yamamoto Y, et al. Dorsal root ganglion pulsed radiofrequency for the management of intractable vertebral metastatic pain: a case series. Pain Med. 2015;7(16):1007-12.
38. Fanous SN, Saleh EG, Abd Elghafar EM, Ghobrial HZ. Randomized controlled trials between dorsal root ganglion thermal radiofrequency and pulsed radiofrequency for the management of intractable metastatic back pain in thoracic vertebral body. Br J Pain. 2021;3(15):270-81.
39. Wang F, Zhou Q, Xiao L, et al. A Randomized Comparative Study of Pulsed Radiofrequency Treatment With or Without Selective Nerve Root Block for Chronic Cervical Radicular Pain. Pain Pract. 2017;17(5):589-95.
40. Vanila M, Singh MD. The Pain Management Best Practices Inter-Agency Task Force (Task Force). 2019.
41. Vuka I, Marciuš T, Došenović S, et al. Efficacy and safety of pulsed radiofrequency as a method of dorsal root ganglia stimulation in patients with neuropathic pain: A systematic review. Pain Med. 2020;21(12):3320-43.
42. Nishihara M, Arai YC, Yamamoto Y, et al. Randomized Trial Combinations of Low-Dose Antidepressants and Low-Dose Pregabalin as Useful Adjuvants to Opioids for Intractable. Painful Bone Metast. 2013;16(5):E547-52.
43. Watkins RG, O'Brien JP, Draugelis R, Jones D. Comparisons of preoperative and postoperative MMPI data in chronic back patients. Spine (Phila Pa 1976). 1986;11(4):385-90. DOI:10.1097/00007632-198605000-00018
44. Bikmullin VN, Klitsenko OA, Rudenko VV. Comparative analysis of Prolo and Watkins scales evaluating economic and functional status. Rossiiskii Neyrokhirurgicheskii Zhurnal imeni Professora AL Polenova. 2015;3(7):5-10 (in Russian).
45. Gushcha AO, Yusupova AR. Evaluation of outcomes of surgical treatment for degenerative diseases of the spine. Russian Journal of Spine Surgery. 2017;14(4):85-94 (in Russian).
46. Carlson CL. Effectiveness of the World Health Organization cancer pain relief guidelines: An integrative review. J Pain Res. 2016;9:515-34.
47. Chun EH, Kim YJ, Woo JH. Which is your choice for prolonging the analgesic duration of single-shot interscalene brachial blocks for arthroscopic shoulder surgery? intravenous dexamethasone 5mg vs. perineural dexamethasone 5mg randomized, controlled, clinical trial. Medicine. 2016;23(95).
48. Ruppert LM, Reilly J. Metastatic spine oncology: Symptom-directed management. Neuro-Oncol Pract. 2020;7:I54-61.
49. Schneider G, Voltz R, Gaertner J. Cancer pain management and bone metastases: An update for the clinician. Breast Care. 2012;7(2):113-20.
50. Steven D. Waldman Atlas of Interventional Pain Management. 2021.
51. Waldron NH, Jones CA, Gan TJ, et al. Impact of perioperative dexamethasone on postoperative analgesia and side-effects: Systematic review and meta-analysis. Br J Anaesthesia. 2013;110(2):191-200.
52. Cosman ER Jr, Cosman ER Sr. Electric and Thermal Field Effects in Tissue Around Radiofrequency Electrodes. Pain Med. 2005;6(6):405-24.
53. Deer TR, Azeem N. Essentials of Radiofrequency Ablation of the Spine and Joints. 2021.
54. Podhajsky RJ, Sekiguchi Y, Kikuchi S, Myers RR. The Histologic Effects of Pulsed and Continuous Radiofrequency Lesions at 42°C to Rat Dorsal Root Ganglion and Sciatic Nerve. Spine. 2005;9(30):1008-13.
55. Sluijter ME, Cosman E, Rittman I. The effects of pulsed radiofrequency fi eld applied to the dorsal root ganglion: a preliminary report. Pain Clin. 1998;11:109-17.
56. Arai YC, Nishihara M, Aono S, et al. Pulsed radiofrequency treatment within brachial plexus for the management of intractable neoplastic plexopathic pain. J Anesthesia. 2013;2(27):298-301.
57. Van Boxem K, van Eerd M, Brinkhuizen T, et al. Radiofrequency and pulsed radiofrequency treatment of chronic pain syndromes: The available evidence. Pain Pract. 2008;5(8):385-93.
58. Munglani R. The longer term effect of pulsed radiofrequency for neuropathic pain. Pain. 1999;80(1-2):437-9. DOI:10.1016/s0304-3959(98)00183-3
59. Dowdall T, Robinson I, Meert TF. Comparison of five different rat models of peripheral nerve injury. Pharmacol Biochem Behav. 2005;1(80):93-108.
60. Sandkühler J, Chen JG, Cheng G, Randić M. Low-Frequency Stimulation of Afferent A-Fibers Induces Long-Term Depression at Primary Afferent Synapses with Substantia Gelatinosa. J Neurosci. 1997;17(16):6483-91.
61. Hetta DF, Mohamed AA, Abdel Eman RM, et al. Pulsed Radiofrequency of the Sacral Roots Improves the Success Rate of Superior Hypogastric Plexus Neurolysis in Controlling Pelvic and Perineal Cancer Pain. Randomized Trial. Pain Physic. 2020;23:149-57.
62. Ren H, Jin H, Jia Z, et al. Pulsed radiofrequency applied to the sciatic nerve improves neuropathic pain by down-regulating the expression of calcitonin gene-related peptide in the dorsal root ganglion. Int J Med Sci. 2018;2(15):153-60.
63. Fu M, Meng L, Ren H, Luo F. Pulsed radiofrequency inhibits expression of P2X3receptors and alleviates neuropathic pain induced by chronic constriction injury in rats. Chin Med J. 2019;14(132):1706-12.
64. Jiang R, Li P, Yao YX, et al. Pulsed radiofrequency to the dorsal root ganglion or the sciatic nerve reduces neuropathic pain behavior, decreases peripheral pro-inflammatory cytokines and spinal β-catenin in chronic constriction injury rats. Regional Anesthesia Pain Med. 2019;7(44):742-6.
65. Vallejo R, Tilley DM, Williams J, et al. Randomized Controlled Trial Pulsed Radiofrequency Modulates Pain Regulatory Gene Expression Along the Nociceptive Pathway. Pain Physician. 2013;16:601-13.
66. Hailong J, Hao R, Zipu J, et al. Pulsed radiofrequency improves neuropathic pain in chronic constriction injury rats through the upregulation of the transcription and translation levels of glial cell line-derived neurotrophic factor. Pain Physician. 2018;21:33-40.
67. Jia Z, Ren H, Li Q, et al. Pulsed Radiofrequency Reduced Neuropathic Pain Behavior in Rats Associated with Upregulation of GDNF Expression. Pain Physician. 2016;19:49-58.
68. Liu CK, Liao WT, Chu YC, et al. Pulsed Radiofrequency Attenuates Complete Freund’s Adjuvant-Induced Epigenetic Suppression of Potassium Chloride Cotransporter 2 Expression. Pain Med. 2017;4(18):807-13.
69. Choi D, Crockard A, Bunger C, et al. Review of metastatic spine tumour classification and indications for surgery: The consensus statement of the Global Spine Tumour Study Group. Eur Spine J. 2010;19;2:215-22.
70. Murali N, Turmezei T, Bhatti S, et al. What is the effectiveness of radiofrequency ablation in the management of patients with spinal metastases? A systematic review and meta-analysis. J Orthopaed Surg Res. 2021;16:1.
Авторы
С.Ф. Кузнецов*, Н.С. Бабкин, А.К. Валиев, Р.М. Кабардаев, К.А. Борзов
ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России, Москва, Россия
*kuzstas@gmail.com
ФГБУ «Национальный медицинский исследовательский центр онкологии им. Н.Н. Блохина» Минздрава России, Москва, Россия
*kuzstas@gmail.com
________________________________________________
Stanislav F. Kuznetsov*, Nikita S. Babkin, Aslan K. Valiev, Ruslan M. Kabardaev, Kirill A. Borzov
Blokhin National Medical Research Center of Oncology, Moscow, Russia
*kuzstas@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.